Literature DB >> 19367450

Positron emission tomography in lung cancer.

Hiroaki Nomori1, Yasuomi Ohba, Kentaro Yoshimoto, Hidekatsu Shibata, Kenji Shiraishi, Takeshi Mori.   

Abstract

Recent advances in positron emission tomography (PET) with 2-deoxy-2-fluoro [F-18]-D: -glucose (FDG) has enabled not only the diagnosis and staging of lung cancer but also the prediction of its malignancy grade. However, FDG-PET has been known to have several pitfalls for imaging of lung cancer. For the effective clinical use of FDG-PET in lung cancer, we reviewed the pitfalls of using FDG-PET in the diagnosis of pulmonary nodules, semiquantitative analysis of FDG-uptake, N-staging, prediction of tumor aggressiveness, prognostic significance, and prediction of pathological response after chemoradiotherapy.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19367450     DOI： 10.1007/s11748-008-0371-3

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN： 1863-6705


  61 in total

1.  Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions.

Authors:  N C Gupta; G M Graeber; H A Bishop
Journal:  Chest       Date:  2000-03       Impact factor: 9.410

2.  The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma.

Authors:  V Ahuja; R E Coleman; J Herndon; E F Patz
Journal:  Cancer       Date:  1998-09-01       Impact factor: 6.860

3.  FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer.

Authors:  Takashi Ohtsuka; Hiroaki Nomori; Akinori Ebihara; Ken-ichi Watanabe; Masahiro Kaji; Tsuguo Naruke; Keiichi Suemasu; Kimiichi Uno
Journal:  Ann Thorac Cardiovasc Surg       Date:  2006-04       Impact factor: 1.520

4.  Remediastinoscopy after induction chemotherapy in non-small cell lung cancer.

Authors:  M Mateu-Navarro; R Rami-Porta; R Bastus-Piulats; L Cirera-Nogueras; G González-Pont
Journal:  Ann Thorac Surg       Date:  2000-08       Impact factor: 4.330

5.  The impact of fluorodeoxyglucose F 18 positron-emission tomography on the surgical staging of non-small cell lung cancer.

Authors:  Hubert Vesselle; Jeffrey M Pugsley; Eric Vallières; Douglas E Wood
Journal:  J Thorac Cardiovasc Surg       Date:  2002-09       Impact factor: 5.209

6.  Standardized uptake values of FDG: body surface area correction is preferable to body weight correction.

Authors:  C K Kim; N C Gupta; B Chandramouli; A Alavi
Journal:  J Nucl Med       Date:  1994-01       Impact factor: 10.057

7.  Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images.

Authors:  Hiroaki Nomori; Kenichi Watanabe; Takashi Ohtsuka; Tsuguo Naruke; Keiichi Suemasu; Kimiichi Uno
Journal:  Lung Cancer       Date:  2004-07       Impact factor: 5.705

8.  Positron emission tomography scanning poorly predicts response to preoperative chemotherapy in non-small cell lung cancer.

Authors:  Jeffrey L Port; Michael S Kent; Robert J Korst; Roger Keresztes; Matthew A Levin; Nasser K Altorki
Journal:  Ann Thorac Surg       Date:  2004-01       Impact factor: 4.330

9.  Mediastinal staging of non-small-cell lung cancer with positron emission tomography.

Authors:  R Chin; R Ward; J W Keyes; R H Choplin; J C Reed; S Wallenhaupt; A S Hudspeth; E F Haponik
Journal:  Am J Respir Crit Care Med       Date:  1995-12       Impact factor: 21.405

10.  A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.

Authors:  R Rosell; J Gómez-Codina; C Camps; J Maestre; J Padille; A Cantó; J L Mate; S Li; J Roig; A Olazábal
Journal:  N Engl J Med       Date:  1994-01-20       Impact factor: 91.245
View more
  3 in total

1.  Accuracy of positron emission tomography in mediastinal node assessment in coal workers with lung cancer.

Authors:  Ozkan Saydam; Mertol Gokce; Ali Kilicgun; Ozgur Tanriverdi
Journal:  Med Oncol       Date:  2011-03-06       Impact factor: 3.064

2.  Consistency and prognostic value of preoperative staging and postoperative pathological staging using 18F-FDG PET/MRI in patients with non-small cell lung cancer.

Authors:  Akiko Kajiyama; Kimiteru Ito; Hirokazu Watanabe; Sunao Mizumura; Shun-Ichi Watanabe; Yasushi Yatabe; Tatsuya Gomi; Masahiko Kusumoto
Journal:  Ann Nucl Med       Date:  2022-10-20       Impact factor: 2.258

Review 3.  PET/CT imaging in lung cancer: indications and findings.

Authors:  Bruno Hochhegger; Giordano Rafael Tronco Alves; Klaus Loureiro Irion; Carlos Cezar Fritscher; Leandro Genehr Fritscher; Natália Henz Concatto; Edson Marchiori
Journal:  J Bras Pneumol       Date:  2015 May-Jun       Impact factor: 2.624
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.